Safe duration of postoperative monitoring for malignant hyperthermia susceptible patients

被引：7

作者：

Pollock, N ^{[1
]}

Langton, E ^{[1
]}

Stowell, K ^{[1
]}

Simpson, C ^{[1
]}

McDonnell, N ^{[1
]}

机构：

[1] Palmerston N Hosp, Dept Anaesthesia & Intens Care, Palmerston North, New Zealand

来源：

ANAESTHESIA AND INTENSIVE CARE | 2004年 / 32卷 / 04期

关键词：

monitoring; postoperative; malignant hyperthermia; post-anaesthetic care unit; non-triggering anaesthesia;

D O I：

10.1177/0310057X0403200407

中图分类号：

R614 [麻醉学];

学科分类号：

100217 ;

摘要：

Postoperative management of malignant hyperthermia (MH) susceptible patients has changed substantially over the last 20 years, with many patients now managed as day cases. Our previous policy was to monitor known MH susceptible patients (and relatives of known MH susceptible individuals not yet investigated by muscle biopsy) for four hours in the Post Anaesthetic Care Unit. However, anaesthetic literature reports suggest that MH reactions usually commence within one hour of anaesthesia. For this reason we conducted a retrospective review of Post Anaesthetic Care Unit data in 254 MH susceptible/related patients treated between 1991 and late 2000. On the basis of this review we instituted a policy change and reduced our monitoring time to one hour in the Post Anaesthetic Care Unit with a further 1.5h in a step-down unit if indicated. A prospective study in a further 68 MH susceptible/related patients showed that no MH reactions were missed due to the shorter monitoring period.

引用

页码：502 / 509

页数：8

共 50 条

[31] A CIRCLE SYSTEM IS BEST WHEN ANESTHETIZING MALIGNANT HYPERTHERMIA SUSCEPTIBLE PATIENTS
ALLEN, G
ANESTHESIOLOGY, 1989, 70 (06) : 1025 - 1026
[32] Preparing a new generation anaesthetic machine for patients susceptible to malignant hyperthermia
Schönell, LHB
Sims, C
Bulsara, M
ANAESTHESIA AND INTENSIVE CARE, 2003, 31 (01) : 58 - 62
[33] POSTOPERATIVE MALIGNANT HYPERTHERMIA - REPLY
GRINBERG, R
GORDON, AS
CANADIAN ANAESTHETISTS SOCIETY JOURNAL, 1984, 31 (01) : 116 - 116
[34] Preparation of the siemens KION anesthetic machine for patients susceptible to malignant hyperthermia
Petroz, GC
Lerman, J
ANESTHESIOLOGY, 2002, 96 (04) : 941 - 946
[35] IS THEOPHYLLINE, AMINOPHYLLINE, OR CAFFEINE (METHYLXANTHINES) CONTRAINDICATED IN MALIGNANT HYPERTHERMIA SUSCEPTIBLE PATIENTS
FLEWELLEN, EH
NELSON, TE
ANESTHESIA AND ANALGESIA, 1983, 62 (01): : 115 - 118
[36] SAFETY OF AMIDE LOCAL-ANESTHETICS IN PATIENTS SUSCEPTIBLE TO MALIGNANT HYPERTHERMIA
DERSHWITZ, M
RYAN, JF
GURALNICK, W
JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 1989, 118 (03): : 276 - 280
[37] Pathological findings in muscle from malignant hyperthermia-susceptible patients
Ibarra M, Carlos A.
Malicdan, May C.
Wu, Shiwen
Murayama, Kumiko
Ichihara, Yasuko
Kikuchi, Hirosato
Noguchi, Satoru
Hayashi, Yukiko
Nonaka, Ikuya
Nishino, Ichizo
NEUROMUSCULAR DISORDERS, 2006, 16 : S149 - S149
[38] Nonimmobilizers do not cause muscle contractures in patients susceptible to malignant hyperthermia
Kindler, CH
MOLECULAR AND BASIC MECHANISMS OF ANESTHESIA, 2002, : 299 - 305
[39] Caffeine impairs intramuscular energy balance in patients susceptible to malignant hyperthermia
Textor, Z
Beer, M
Anetseder, M
Köstler, H
Kagerbauer, E
Kenn, W
Hahn, D
Roewer, N
MUSCLE & NERVE, 2003, 28 (03) : 353 - 358
[40] USE OF ATRACURIUM AND GLYCOPYRROLATE DURING ANESTHESIA OF PATIENTS SUSCEPTIBLE TO MALIGNANT HYPERTHERMIA
ORDING, H
NIELSEN, VG
ACTA ANAESTHESIOLOGICA SCANDINAVICA, 1985, 29 : 64 - 64

← 1 2 3 4 5 →